ALCAM and colonic neoplasm: It is less likely that a known marker for colon cancer stem cells, such as CD44, CD166, EpCAM, and Lgr5, has the potential just like Pten-related pathway in leukemia, which could distinguish hematopoietic stem cells from leukemia-initiating cells [54-57].